PRESS-RELEASEV2

Jonathan Arnott MEP welcomes investment from GlaxoSmithKline

The decision by pharmaceutical giant GlaxoSmithKline to invest £275m at its UK manufacturing sites including in County Durham has been welcomed by local MEP Jonathan Arnott.

“This is great news not just for the local area but for Britain in general and I am delighted with the firm’s view that despite Brexit the country remains an attractive location.

“There was such doom-mongering about the economic future of the UK before the Referendum vote but already we are seeing that the fears were exaggerated beyond belief and the GSK investment decision demonstrates this,” said Mr Arnott, UKIP MEP for the North East.

The company, which has nine sites employing a total of 6,000 people, will invest a total of £92 million at the Barnard Castle site to build a new sterilising facility.

“Investment is desperately needed in my constituency which repeatedly comes out the worst in the country in terms of employment, wages and house prices. I earnestly hope that this GSK decision will be mirrored by other firms.”

Mr Arnott, who is standing for leadership of UKIP following the resignation of Nigel Farage, added, “Regardless of whether I become leader or not I will continue to do everything I can for the North East which has been shamefully neglected for decades by successive governments.”